Abstract 2927: CS2011: A novel bispecific antibody targeting EGFR and HER3 that demonstrates promising antitumor activity in preclinical evaluation
Chuan Wang(Ascepion Pharmaceuticals (China)), Jianxin Yang(Ascepion Pharmaceuticals (China)), Jingyu Sun(Shanghai East Hospital), Fei Ma(Shenzhen University), Ning Zhang(Ascepion Pharmaceuticals (China)), Xuelian Liu(Ascepion Pharmaceuticals (China)), Yi Sun(Ascepion Pharmaceuticals (China)), Yongli Yang(Southwest Forestry University), Yongwang Li(Shenzhen Third People’s Hospital), Xinling Zhang(Qingdao University), Mengyao Zhu(Ascepion Pharmaceuticals (China))
Cited by 1
Related Papers
Design and Mechanisms of Asymmetric Supercapacitors
|Chemical Reviews|2018|3.6k
Crafting Mussel‐Inspired Metal Nanoparticle‐Decorated Ultrathin Graphitic Carbon Nitride for the Degradation of Chemical Pollutants and Production of Chemical Resources
|Advanced Materials|2019|422
Bridging the Gap between Reality and Ideal in Chemical Vapor Deposition Growth of Graphene
|Chemical Reviews|2018|396
Towards super-clean graphene
|Nature Communications|2019|217